1. Home
  2. MAIA vs NHTC Comparison

MAIA vs NHTC Comparison

Compare MAIA & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • NHTC
  • Stock Information
  • Founded
  • MAIA 2018
  • NHTC 1988
  • Country
  • MAIA United States
  • NHTC United States
  • Employees
  • MAIA N/A
  • NHTC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • NHTC Diversified Commercial Services
  • Sector
  • MAIA Health Care
  • NHTC Miscellaneous
  • Exchange
  • MAIA Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • MAIA 46.7M
  • NHTC 56.0M
  • IPO Year
  • MAIA 2022
  • NHTC 1995
  • Fundamental
  • Price
  • MAIA $2.15
  • NHTC $4.87
  • Analyst Decision
  • MAIA
  • NHTC
  • Analyst Count
  • MAIA 0
  • NHTC 0
  • Target Price
  • MAIA N/A
  • NHTC N/A
  • AVG Volume (30 Days)
  • MAIA 79.7K
  • NHTC 14.7K
  • Earning Date
  • MAIA 05-13-2025
  • NHTC 04-30-2025
  • Dividend Yield
  • MAIA N/A
  • NHTC 16.25%
  • EPS Growth
  • MAIA N/A
  • NHTC 0.43
  • EPS
  • MAIA N/A
  • NHTC 0.05
  • Revenue
  • MAIA N/A
  • NHTC $42,963,000.00
  • Revenue This Year
  • MAIA N/A
  • NHTC N/A
  • Revenue Next Year
  • MAIA N/A
  • NHTC N/A
  • P/E Ratio
  • MAIA N/A
  • NHTC $98.63
  • Revenue Growth
  • MAIA N/A
  • NHTC N/A
  • 52 Week Low
  • MAIA $1.40
  • NHTC $4.02
  • 52 Week High
  • MAIA $5.99
  • NHTC $7.40
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 70.43
  • NHTC 46.75
  • Support Level
  • MAIA $1.51
  • NHTC $4.85
  • Resistance Level
  • MAIA $1.61
  • NHTC $4.98
  • Average True Range (ATR)
  • MAIA 0.12
  • NHTC 0.27
  • MACD
  • MAIA 0.06
  • NHTC -0.01
  • Stochastic Oscillator
  • MAIA 90.91
  • NHTC 20.26

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: